NEW BIPHENYL COMPOUND OR ITS SALT Russian patent published in 2020 - IPC C07D207/04 C07D207/14 C07D211/58 C07D401/10 C07D403/10 C07D405/10 C07D413/10 C07D417/10 C07D451/04 C07D471/08 C07D471/10 C07D487/08 C07D487/10 A61K31/40 A61K31/404 A61K31/416 A61K31/4184 A61K31/4196 A61K31/424 A61K31/428 A61K31/437 A61K31/438 A61K31/439 A61K31/4439 A61K31/445 A61K31/46 A61K31/4995 A61K31/538 A61P35/00 

Abstract RU 2726622 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: invention relates to a compound of formula (I):

(I),

where ring A is a monocyclic, bridged cyclic or spirocyclic 5–12-member nitrogen-containing saturated heterocyclic group, having 1 to 2 nitrogen atoms and 0 to 1 oxygen atoms as heteroatoms, ring B is a monocyclic or bicyclic 5–12-member unsaturated hydrocarbon or monocyclic or bicyclic 5–12-member unsaturated heterocyclic group which can be substituted with oxo, which has 0 to 3 nitrogen atoms, 0 to 1 sulfur atoms and 0 to 2 oxygen atoms as heteroatoms and which has at least one of nitrogen, sulfur and oxygen, X is O or S, R1 is nitro or cyano, R2 is halogen, R3 is amino, mono- or di (C1-C6 alkyl) amino, (C3-C6 cycloalkyl) amino or C1-C6 alkyl, R4 is halogen; nitro; cyano; carboxy; C1-C6 alkyl, optionally substituted with 1–3 substitutes selected from halogen, carboxy, C1-C6 alkoxy, hydroxy, (C2-C7 acyl) oxy, amino, optionally substituted with C2-C7 acyl, C3-C6 cycloalkyl substituted with hydroxy, or carbamoyl, optionally mono- or disubstituted with C1-C6 alkyl; C2-C6 alkenyl; C1-C6 alkoxy optionally substituted with 1 substituent selected from hydroxy, C1-C6 alkyl, optionally substituted with hydroxy, or monocyclic 6–10-member unsaturated hydrocarbon; C3-C6 cycloalkyl, optionally substituted with 1 substituent selected from C1-C6 alkyl, optionally substituted hydroxy, carbamoyl, substituted with monocyclic 6–10-member unsaturated hydrocarbon, (C1-C6 alkoxy) (C1-C6 alkyl) or C3-C6 cycloalkyl substituted with hydroxy; mono- or di (C1-C6 alkyl) amino; or carbamoyl, optionally substituted with 1 or 2 substitutes, which are C1-C6 alkyl, where, if two or more substituents are present, the substituents can be identical or different, l is integer from 0 to 2, m is integer from 0 to 2 and n is integer from 0 to 5, where, if l is equal to 2, two R2 can be identical or different, if m is equal to 2, two R3 can be identical or different and if n equals from 2 to 5, from two to five R4 can be identical or different.

EFFECT: disclosed compounds are inhibitors of LSD1 and exhibit anti-tumor activity.

12 cl, 39 tbl, 281 ex

Similar patents RU2726622C2

Title Year Author Number
NEW BIPHENYL COMPOUND OR ITS SALT 2018
  • Yamashita, Satoshi
  • Ogawa, Takahiro
RU2765152C2
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION 2018
  • Hatanaka, Ryo
RU2789449C2
ANTITUMOR EFFECT ENHANCER USING NEW BIPHENYL COMPOUND 2018
  • Osada, Akiko
RU2765153C2
DIPEPTIDYL PEPTIDASE-IV INHIBITORS 2010
  • Balasubramanian Gopalan
  • Sakamuri Sukumar
  • Singkh Gadzhendra
  • Dkharmalingam Sivanesan
  • Pooppadi Ksavier Franklin
  • Narajanan Shridkhar
  • Mookkan Dzhejamurugan
  • Balasubramanian Dzheganatkha Sivakumar
  • Radzhalingam Agneesvari
  • Kulatkhingal Dzhajanarajan
RU2574410C2
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS 2021
  • Ouen, Defidd Ris
  • Pettersson, Martin Yungchin
  • Riz, Mettyu Richard
  • Semmons, Mettyu Forrest
  • Tattl, Dzhejmison Brajs
  • Verkhust, Patrik Robert
  • Vej, Lyutsin
  • Yan, Syaotszin
  • Yan, Tsingyuj
RU2820150C2
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS 2021
  • Owen, Dafydd Rhys
  • Pettersson, Martin Youngjin
  • Reese, Matthew Richard
  • Sammons, Matthew Forrest
  • Tuttle, Jamison Bryce
  • Verhoest, Patrick Robert
  • Wei, Liuqing
  • Yang, Xiaojing
  • Yang, Qingyi
RU2786722C1
NOVEL NICOTINAMIDE DERIVATIVE OR ITS SALT 2011
  • Fudzivara Khidejasu
  • Midzumoto Sinsuke
  • Kubo Jokhei
  • Nakata Khijoku
  • Nagivara Sindzi
  • Baba Jasutaka
  • Tamura Takasi
  • Kunijosi Khidenobu
  • Masiko Tomojuki
  • Jamamoto Mari
RU2576623C2
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS 2008
  • Bonnert Rodzher Viktor
  • Burkamp Frank
  • Koks Rona Dzhejn
  • De Souza Sajmon
  • Dikkinson Mark
  • Khant Sajmon Frejzer
  • Megani Premdzhi
  • Pimm Osten
  • Sangani Khitesh Dzhajantilal
RU2479584C2
PROTEOLYSIS MODULATORS AND RELATED USES 2019
  • Crew, Andrew P.
  • Hornberger, Keith R.
  • Wang, Jing
  • Dong, Hanqing
  • Berlin, Michael
  • Crews, Craig M.
RU2805511C2
MENIN-MLL INTERACTION INHIBITORS 2017
  • Kakatyan Salvasion
  • Klejrmon Devid A.
  • Dillard Lourens Vejn
  • Dun Chengo
  • Fan I
  • Tszya Lantsi
  • Lotesta Stefen D.
  • Markus Endryu
  • Morales-Ramos Enzhel
  • Singkh Suresh B.
  • Venkatraman Shankar
  • Yuan Tszin
  • Chzhen Yatszyun
  • Chzhuan Linkhan
  • Perent Stefan D.
  • Khyuston Trejvis L.
RU2799820C2

RU 2 726 622 C2

Authors

Yamashita, Satoshi

Ogawa, Takahiro

Komatani, Hideya

Dates

2020-07-15Published

2016-11-25Filed